Literature DB >> 35704105

Characterization of Some Microorganisms from Human Stool Samples and Determination of Their Effects on CT26 Colorectal Carcinoma Cell Line.

Münevver Kahraman1, Aynur Gül Karahan2, Mustafa Ender Terzioğlu3.   

Abstract

The present study aimed to isolate and identify the potential probiotic, pathobiont, and pathogenic microorganisms in the stool samples of 12 healthy individuals and evaluate their in vitro effects on cancer formation. A total of 83 strains were isolated from the stool samples and identified using MALDI-Biotyper. Fourteen of the isolates were identified as Candida spp., three isolates were identified as Cryptococcus neoformans, 55 isolates were identified as lactic acid bacteria, and the remaining isolates belonged to different 11 bacterial genera. Important microbial properties for cancer prevention and some probiotic properties were examined. All strains maintained their viability under acidic conditions and in media containing bile salts. Of the bacterial strains, 62.5% were resistant to ampicillin, chloramphenicol, gentamicin, erythromycin, kanamycin, penicillin, streptomycin, tetracycline, and vancomycin. All yeast strains were resistant to ketoconazole and susceptible to nystatin. The susceptibility of the strains to fluconazole, voriconazole, amphotericin B, and itraconazole varied. Fifty-nine percent of the strains produced EPS and 21.7% showed proteolytic activity (PA). Of the strains, 15.7% both produced exopolysaccharides (EPS) and had PA. The antioxidant activity (AOA) varied depending on the strains. The pathobiont and pathogenic microorganisms promoted tumor formation, while potential probiotic microorganisms had a suppressive effect on tumor formation (P > 0.01). One yeast (Candida kefyr MK17) and three lactic acid bacteria strains (Lacticaseibacillus paracasei MK73, Lactiplantibacillus plantarum MK55, Limosilactobacillus mucosae MK45) have superior potential thanks to their anticarcinogenic properties as well as tolerance to gastrointestinal tract conditions. Stool samples of each individual contain various potential probiotic, pathobiont, and pathogenic microorganisms.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Year:  2022        PMID: 35704105     DOI: 10.1007/s00284-022-02915-4

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  30 in total

1.  Immunological Consequences of Intestinal Fungal Dysbiosis.

Authors:  Matthew L Wheeler; Jose J Limon; Agnieszka S Bar; Christian A Leal; Matthew Gargus; Jie Tang; Jordan Brown; Vincent A Funari; Hanlin L Wang; Timothy R Crother; Moshe Arditi; David M Underhill; Iliyan D Iliev
Journal:  Cell Host Microbe       Date:  2016-05-26       Impact factor: 21.023

Review 2.  Carcinogenesis and therapeutics: the microbiota perspective.

Authors:  Matthew C B Tsilimigras; Anthony Fodor; Christian Jobin
Journal:  Nat Microbiol       Date:  2017-02-22       Impact factor: 17.745

3.  Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice.

Authors:  Andrew L Goodman; George Kallstrom; Jeremiah J Faith; Alejandro Reyes; Aimee Moore; Gautam Dantas; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

4.  Identification of lactic acid bacteria isolated from the fecal samples of healthy humans and patients with dyspepsia, and determination of their ph, bile, and antibiotic tolerance properties.

Authors:  Gülden Başyiğit Kiliç; Aynur Gül Karahan
Journal:  J Mol Microbiol Biotechnol       Date:  2010-07-29

Review 5.  To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes.

Authors:  Jens Walter; María X Maldonado-Gómez; Inés Martínez
Journal:  Curr Opin Biotechnol       Date:  2017-09-13       Impact factor: 9.740

6.  Plasmid stability of potential probiotic Lactobacillus plantarum strains in artificial gastric juice, at elevated temperature, and in the presence of novobiocin and acriflavine.

Authors:  H Sağlam; A G Karahan
Journal:  Arch Microbiol       Date:  2020-08-16       Impact factor: 2.552

7.  Properties of a New Probiotic Candidate and Lactobacterin-TK2 Against Diarrhea in Calves.

Authors:  Togzhan Boranbayeva; Aynur Gül Karahan; Zhanara Tulemissova; Raya Myktybayeva; Serkan Özkaya
Journal:  Probiotics Antimicrob Proteins       Date:  2020-09       Impact factor: 4.609

Review 8.  Exopolysaccharides from probiotic bacteria and their health potential.

Authors:  J Angelin; M Kavitha
Journal:  Int J Biol Macromol       Date:  2020-06-22       Impact factor: 6.953

9.  Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.

Authors:  Jason C Sniffen; Lynne V McFarland; Charlesnika T Evans; Ellie J C Goldstein
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

10.  Flavor Chemical Profiles of Cabernet Sauvignon Wines: Six Vintages from 2013 to 2018 from the Eastern Foothills of the Ningxia Helan Mountains in China.

Authors:  Xue Zhang; Keqing Wang; Xiaobo Gu; Xiaohan Sun; Gang Jin; Junxiang Zhang; Wen Ma
Journal:  Foods       Date:  2021-12-23
View more
  1 in total

1.  Lactobacilli metabolites restore E-cadherin and suppress MMP9 in cervical cancer cells.

Authors:  Krupali Pawar; Clara Aranha
Journal:  Curr Res Toxicol       Date:  2022-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.